|
Volumn 45, Issue 3, 2013, Pages 1022-1025
|
Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: Case reports
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
BASILIXIMAB;
COMPLEMENT COMPONENT C4D;
CREATININE;
ECULIZUMAB;
HEMOGLOBIN;
HLA ANTIBODY;
HLA B13 ANTIGEN;
HLA DR4 ANTIGEN;
IMMUNOGLOBULIN;
MYCOPHENOLIC ACID;
PREDNISOLONE;
RITUXIMAB;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ACUTE KIDNEY TUBULE NECROSIS;
ACUTE PANCREATITIS;
ADULT;
ANTIBODY MEDIATED REJECTION;
ANURIA;
CASE REPORT;
CHRONIC KIDNEY FAILURE;
CONFERENCE PAPER;
CREATININE BLOOD LEVEL;
DESENSITIZATION;
DISEASE SEVERITY;
DRUG WITHDRAWAL;
FEMALE;
FEVER;
GLOMERULOPATHY;
HEMODIALYSIS;
HEMOGLOBIN BLOOD LEVEL;
HEMOLYSIS;
HUMAN;
HYPERTENSION;
IMMUNOASSAY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY CORTEX NECROSIS;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TUBULE NECROSIS;
LACTATE DEHYDROGENASE BLOOD LEVEL;
LEUKOPENIA;
MEDICAL HISTORY;
PLASMAPHERESIS;
POSTOPERATIVE PERIOD;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
SALVAGE THERAPY;
SINGLE DRUG DOSE;
STEROID THERAPY;
T LYMPHOCYTE;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
URINE VOLUME;
VASCULITIS;
ADULT;
ANTIBODIES, MONOCLONAL, HUMANIZED;
FEMALE;
GRAFT REJECTION;
HUMANS;
KIDNEY TRANSPLANTATION;
SALVAGE THERAPY;
|
EID: 84876868259
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2013.02.062 Document Type: Conference Paper |
Times cited : (47)
|
References (11)
|